|Chemical and physical data|
|Molar mass||342.743 g/mol g·mol−1|
|3D model (JSmol)|
LGD-3303 is a drug which acts as a selective androgen receptor modulator (SARM), with good oral bioavailability. It is a selective agonist for the androgen receptor, producing functional selectivity with effective dissociation of anabolic and androgenic effects, acting as a partial agonist for androgenic effects, but a full agonist for anabolic effects. It has been investigated as a possible treatment for osteoporosis, and was shown in animal studies to enhance the effectiveness of a bisphosphonate drug.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|